CYP2C9 Index Natura structuraque biochemica | Genetica | Pharmaca ad CYP2C9 relata | Notae | Nexus externi | Tabula navigationis"Structure and dynamics of the membrane-bound cytochrome P450 2C9""Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site"
Cytochromata P450
-atis, n.Numerus ECcytochromatum P450polypeptidumacidis aminicisgenichromosomate 10
Cave: notitiae huius paginae nec praescriptiones nec consilia medica sunt. |
---|
Cytochroma P450 CYP2C9 (-atis, n.) (Numerus EC: 1.14.13.48) est haemoproteinum et pars gregis cytochromatum P450.
Index
1 Natura structuraque biochemica
2 Genetica
3 Pharmaca ad CYP2C9 relata
4 Notae
5 Nexus externi
Natura structuraque biochemica |
Cytochroma P450 CYP2C9 est et polypeptidum et haemoproteinum, quod ex 490 acidis aminicis (massa 55.628 Da) constitutum est. Intra cellulam enzymum hoc in ancoris membranae stat[1].
Genetica |
Nomen geni cytochromatis est CYP2C9 locus cuius geneticus in chromosomate 10 humano locatus est (10q23.33).
Pharmaca ad CYP2C9 relata |
Pharmaca relata ad CYP2C9[2][3]. | ||
Substrati | Inhibitores[4] | Inductores[5] |
---|---|---|
|
|
|
Notae |
↑ Cojocaru V, Balali-Mood K, Sansom MS, Wade RC (2011). "Structure and dynamics of the membrane-bound cytochrome P450 2C9". PLoS Comput Biol 7 (8): e1002152
↑ Cozza KL, Armstrong SC (2001). The Cytochrome P450 System. Drug Interaction Principles for Medical Practice. Washington, DC: American Psychiatric Publishing
↑ Preskorn SH (1996). Clinical Pharmacology of Selective Serotonin Reuptake Inhibitors. 1st ed.: Professional Communications, Inc.
↑ Inhibitor cum subtratorum effectibus fortioribus
↑ Inductor cum subtratorum effectibus minoribus
↑ Berka K, Hendrychová T, Anzenbacher P, Otyepka M (2011). "Membrane position of ibuprofen agrees with suggested access path entrance to cytochrome P450 2C9 active site". J Phys Chem A 115 (41): 11248-55
Nexus externi |
- Descriptio genetica CYP2C9: https://ghr.nlm.nih.gov/gene/CYP2C9#